XTL Biopharmaceuticals Ltd.
(NASDAQ : XTLB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.70%567.611.0%$845.24m
MDTMedtronic Plc 1.11%77.770.6%$669.55m
DHRDanaher Corp. 1.38%271.930.7%$642.08m
ABTAbbott Laboratories 1.78%106.680.8%$535.26m
ABMDABIOMED, Inc. 0.74%380.583.3%$525.30m
ISRGIntuitive Surgical, Inc. 1.83%272.850.8%$499.47m
BDXBecton, Dickinson & Co. 0.33%246.391.0%$429.86m
EWEdwards Lifesciences Corp. 0.18%72.710.4%$406.06m
SYKStryker Corp. 2.81%248.881.3%$325.66m
DXCMDexCom, Inc. 4.25%122.921.9%$301.99m
BAXBaxter International, Inc. 0.54%52.631.8%$271.80m
BSXBoston Scientific Corp. 1.21%46.181.0%$255.91m
AAgilent Technologies, Inc. 1.78%156.461.7%$221.91m
WSTWest Pharmaceutical Services, Inc. 0.07%236.051.6%$184.84m
ALGNAlign Technology, Inc. 1.37%189.896.4%$178.89m

Company Profile

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.